William Blair Starts Diplomat Pharmacy (DPLO) at Outperform
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/26/2026
- Nasdaq lags on angst over AI spending ahead of earnings reports
- Elon Musk’s trillion-dollar meltdown: How SpaceX and Tesla erased $700 billion
- Intel jumps 10% after AI-fueled quarter crushes estimates, upbeat outlook
- Oil falls on report China pushing for end US-Iran war
- Why Meta, Microsoft, and Nvidia are championing open-weight AI
- FDA approves Tylenol with Naproxen as first OTC combo pain reliever
- AMD (AMD) PT Raised to $1,250 at Baird
- Pakistan, Iran explore path towards new talks with US in a China-initiated push, sources say
- Elon Musk’s trillion-dollar meltdown: How SpaceX and Tesla erased $700 billion
- Nasdaq lags on angst over AI spending ahead of earnings reports
Credit Suisse Starts Diplomat Pharmacy (DPLO) at Outperform
November 19, 2014 9:25 AM ESTCredit Suisse initiated coverage on Diplomat Pharmacy (NYSE: DPLO) with an Outperform rating and a price target of $29.00.
For an analyst ratings summary and ratings history on Diplomat Pharmacy click here. For more ratings news on Diplomat Pharmacy click here.
Shares of Diplomat Pharmacy closed at $24.01 yesterday.
... MoreWells Fargo Starts Diplomat Pharmacy (DPLO) at Market Perform
November 19, 2014 8:50 AM ESTWells Fargo initiated coverage on Diplomat Pharmacy (NYSE: DPLO) with a Market Perform rating and a price target of $24-$26.
For an analyst ratings summary and ratings history on Diplomat Pharmacy click here. For more ratings news on Diplomat Pharmacy click here.
Shares of Diplomat Pharmacy closed at $24.01 yesterday.
... MoreJPMorgan Starts Diplomat Pharmacy (DPLO) at Overweight
November 19, 2014 7:29 AM ESTJPMorgan initiated coverage on Diplomat Pharmacy (NYSE: DPLO) with an Overweight rating and a price target of $28.00.
For an analyst ratings summary and ratings history on Diplomat Pharmacy click here. For more ratings news on Diplomat Pharmacy click here.
Shares of Diplomat Pharmacy closed at $24.01 yesterday.
... MoreLeerink Swann Starts Diplomat Pharmacy (DPLO) at Outperform
November 19, 2014 7:28 AM ESTLeerink Swann initiated coverage on Diplomat Pharmacy (NYSE: DPLO) with an Outperform rating and a price target of $30.00.
For an analyst ratings summary and ratings history on Diplomat Pharmacy click here. For more ratings news on Diplomat Pharmacy click here.
Shares of Diplomat Pharmacy closed at $24.01 yesterday.
... More